Journal of Nuclear Medicine September 2024, jnumed.124.267964; DOI: https://doi.org/10.2967/jnumed.124.267964 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267624; DOI: https://doi.org/10.2967/jnumed.124.267624 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267751; DOI: https://doi.org/10.2967/jnumed.124.267751 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267736; DOI: https://doi.org/10.2967/jnumed.124.267736 ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
Journal of Nuclear Medicine September 2024, jnumed.123.267215; DOI: https://doi.org/10.2967/jnumed.123.267215 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267578; DOI: https://doi.org/10.2967/jnumed.124.267578 ...
Dual Somatostatin Receptor/ 18 F-FDG PET/CT Imaging in Patients with Well-Differentiated, Grade 2 and 3 Gastroenteropancreatic Neuroendocrine Tumors ...
Objectives Primary and metastatic bone cancer are significant sources of morbidity and mortality in cancer patients. Available treatments include bisphosphonates, anti-inflammatory and opioid pain ...
Journal of Nuclear Medicine August 2024, jnumed.124.267685; DOI: https://doi.org/10.2967/jnumed.124.267685 ...
Journal of Nuclear Medicine August 2024, jnumed.124.267923; DOI: https://doi.org/10.2967/jnumed.124.267923 ...